SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438234
Filing Date
2013-11-12
Accepted
2013-11-12 16:06:34
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d588485d10q.htm 10-Q 503648
2 EX-10.1 d588485dex101.htm EX-10.1 6767
3 EX-31.1 d588485dex311.htm EX-31.1 9163
4 EX-31.2 d588485dex312.htm EX-31.2 9142
5 EX-32.1 d588485dex321.htm EX-32.1 4068
6 EX-32.2 d588485dex322.htm EX-32.2 4047
  Complete submission text file 0001193125-13-438234.txt   2664030

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cort-20130930.xml EX-101.INS 263729
8 XBRL TAXONOMY EXTENSION SCHEMA cort-20130930.xsd EX-101.SCH 24138
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20130930_cal.xml EX-101.CAL 37590
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20130930_def.xml EX-101.DEF 148515
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20130930_lab.xml EX-101.LAB 204286
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20130930_pre.xml EX-101.PRE 173007
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 131210196
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1